Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Merck KGaA banner

Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 151.25 EUR 0.63% Market Closed
Market Cap: €65.8B
Write Note Create Alert

Intrinsic Value

Is MRK undervalued or overvalued?

See the intrinsic value estimate for Merck KGaA and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MRK Intrinsic Value
LOCKED
Unlock
Today vs. history

MRK looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with MRK’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor MRK
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €151.25
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MRK

Fundamental Analysis

What Merck KGaA Does

Pharmaceuticals Health Care

Merck KGaA is a German science and technology company that makes medicines, lab tools, and specialty materials. Its healthcare business sells prescription drugs and treatments, especially in cancer, fertility, and neurology. Its life science business sells chemicals, testing products, and equipment that researchers and drugmakers use in labs and factories.

Headquarters
Germany DE
Employees
62 461
IPO date
Oct 20, 1995
Read the full company overview
View Company Overview

Merck KGaA has no economic moat

No Moat Narrow Wide

Competing medicines and alternative suppliers leave Merck KGaA without dependable protection across its businesses. Its patents and established customer relationships protect some products, but do not provide a lasting barrier around the whole company.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Merck KGaA

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue MRK Research

Summary
MRK intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRK stock valuation using valuation multiples.
Wall St Estimates
MRK price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Merck KGaA listings:
OTC • USD
MKGAF
 OTC • USD
MKKGY
 F • EUR
MRK
 XHAM • EUR
MRK
 F • EUR
MRKC
 XMUN • EUR
MRK
 SWB • EUR
MRK
 DUS • EUR
MRK
 XHAN • EUR
MRK
Discover More
What is the Intrinsic Value of one MRK stock?

The intrinsic value for Merck KGaA (MRK) under the Base Case is hidden EUR.

Is MRK stock undervalued or overvalued?

Compared with the current market price of 151.25 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.